Clinical efficacy and safety of favipiravir in the treatment of COVID-19 patients

被引:20
作者
Chen, Ping-Jen [1 ]
Chao, Chien-Ming [2 ]
Lai, Chih-Cheng [3 ]
机构
[1] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan
[2] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan
[3] Kaohsiung Vet Gen Hosp, Tainan Branch, Dept Internal Med, Tainan, Taiwan
关键词
D O I
10.1016/j.jinf.2020.12.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:199 / 200
页数:2
相关论文
共 6 条
[1]   RETRACTED: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study (Retracted Article) [J].
Cai, Qingxian ;
Yang, Minghui ;
Liu, Dongjing ;
Chen, Jun ;
Shu, Dan ;
Xia, Junxia ;
Liao, Xuejiao ;
Gu, Yuanbo ;
Cai, Qiue ;
Yang, Yang ;
Shen, Chenguang ;
Li, Xiaohe ;
Peng, Ling ;
Huang, Deliang ;
Zhang, Jing ;
Zhang, Shurong ;
Wang, Fuxiang ;
Liu, Jiaye ;
Chen, Li ;
Chen, Shuyan ;
Wang, Zhaoqin ;
Zhang, Zheng ;
Cao, Ruiyuan ;
Zhong, Wu ;
Liu, Yingxia ;
Liu, Lei .
ENGINEERING, 2020, 6 (10) :1192-1198
[2]  
Chen C, 2020, FAVIPIRAVIR VERSUS A
[3]   AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial [J].
Ivashchenko, Andrey A. ;
Dmitriev, Kirill A. ;
Vostokova, Natalia V. ;
Azarova, Valeria N. ;
Blinow, Andrew A. ;
Egorova, Alina N. ;
Gordeev, Ivan G. ;
Ilin, Alexey P. ;
Karapetian, Ruben N. ;
Kravchenko, Dmitry, V ;
Lomakin, Nikita, V ;
Merkulova, Elena A. ;
Papazova, Natalia A. ;
Pavlikova, Elena P. ;
Savchuk, Nikolay P. ;
Simakina, Elena N. ;
Sitdekov, Tagir A. ;
Smolyarchuk, Elena A. ;
Tikhomolova, Elena G. ;
Yakubova, Elena, V ;
Ivachtchenko, Alexandre, V .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) :531-534
[4]   Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial [J].
Lou, Yan ;
Liu, Lin ;
Yao, Hangping ;
Hu, Xingjiang ;
Su, Junwei ;
Xu, Kaijin ;
Luo, Rui ;
Yang, Xi ;
He, Lingjuan ;
Lu, Xiaoyang ;
Zhao, Qingwei ;
Liang, Tingbo ;
Qiu, Yunqing .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 157
[5]  
Saito S., 2020, J INFECT
[6]   Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial [J].
Udwadia, Zarir F. ;
Singh, Pawan ;
Barkate, Hanmant ;
Patil, Saiprasad ;
Rangwala, Shabbir ;
Pendse, Amol ;
Kadam, Jatin ;
Wu, Wen ;
Caracta, Cynthia F. ;
Tandon, Monika .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 103 :62-71